Assessment of Risk Factors Associated with Common Fungal Pathogens Causing Otomycosis at a Tertiary Care Hospital in South India

Download Article

DOI: 10.21522/TIJPH.2013.12.03.Art019

Authors : Punithavathi V, Aishwarya J Ramalingam, Sameena Khan, Chitralekha Saikumar

Abstract:

Otomycosis is one of the most prevalent fungal diseases of the external auditory canal in the tropical and sub-tropical regions of the world. Numerous environmental and host factors can put a person at risk for otomycosis. This cross-sectional study was undertaken over a one-year period at a tertiary care hospital, in South India after approval from Institutional Human Ethics Committee (IHEC), as there is limited data available on the clinical-mycological profile and its association with various risk factors in our region in the recent past. 90 ear swabs from clinically diagnosed otomycosis patients were sent to the laboratory for mycological examination from the Ear, Nose, and Throat (ENT) out-patient Department. Their clinical data was evaluated using a self-administered questionnaire. Mycological examination yielded 63 fungal isolates with Aspergillus niger as the predominant organism followed by other fungi; common risk factors identified were diabetes mellitus (92%), CSOM patients on steroid drops (91.6%), swimming (80%), CSOM patients on antibiotic drops (75%) with a significant association of p<0.05 between the above-mentioned risk factors and otomycosis. The current study highlights that proper identification of the causative agents is mandatory to prevent complications and recurrences, even when the patients' otoscopic findings and clinical presentations strongly suggest a fungal infection. Comparable with other superficial fungal infections, otomycosis does not represent a threat to life. However, prompt microbiological identification are essential for timely and effective therapy to avert major issues from otomycosis.

References:

[1].   Ibekwe, T. S., & Nwaorgu, O. G., 2011, Classification and Management Challenges of Otitis Media in a Resource-Poor Country. Nigerian journal of clinical practice, 14(3), 262-262. https://doi.org/10.4103/1119-3077.86764

[2].   Agarwal, P., & Devi, L. S., 2017, Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. Journal of Clinical and Diagnostic Research: JCDR, 11(6): DC14-DC18. https://doi.org/10.7860/JCDR/2017/25865.10068

[3].    Mofatteh, M. R., Naseripour Yazdi, Z., Yousefi, M., Namaei, M.H., 2018, Comparison of the Recovery Rate of Otomycosis Using Betadine and Clotrimazole Topical Treatment. Brazilian Journal of Otorhinolaryngology, 84(4):404–409. https://doi.org/10.1016/j.bjorl.2017.04.004

[4].   Ho, T., Vrabec, J. T., Yoo, D., & Coker, N. J., 2006, Otomycosis: clinical features and treatment implications. Otolaryngology-Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 135(5), 787–791. https://doi.org/10.1016/j.otohns.2006.07.008

[5].   Malcolm, T. R., & Chin‐Hong, P. V., 2013, Endemic Mycoses in Immunocompromised Hosts. Current Infectious Diseases Reports, 15(6), 536-543. https://doi.org/10.1007/s11908-013-0387-4

[6].   Tasić-Otašević, S., Golubović, M., Đenić, S., Ignjatović, A., Stalević, M., Momčilović, S., Bojanović, M., Arsić-Arsenijević, V., 2020, Species Distribution Patterns and Epidemiological Characteristics of Otomycosis in Southeastern Serbia. Journal de Mycologie Médicale, 30(3), 101011. https://doi.org/10.1016/j.mycmed.2020.101011

[7].   Pfaller, M. A., & Diekema, D. J., 2004, Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance Beyond Candida Albicans and Aspergillus Fumigatus. Journal of Clinical Microbiology, 42(10), 4419-4431. https://doi.org/10.1128/jcm.42.10.4419-4431.2004

[8].   Ostrowski, V. B., & Wiet, R J., 1996, Pathologic Conditions of the External Ear and Auditory Canal. Postgraduate Medicine, 100(3), 223-237. https://doi.org/10.3810/pgm.1996.09.79

[9].   Fisher, M. C., Gurr, S. J., Cuomo, C. A., Blehert, D. S., Jin, H., Stukenbrock, E. H., Stajich, J. E., Kahmann, R., Boone, C., Denning, D. W., Gow, N. A. R., Klein, B. S., Kronstad, J. W., Sheppard, D. C., Taylor, J. W., Wright, G. D., Heitman, J., Casadevall, A., & Cowen, L. E., 2020, Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture. Microbiology, 11(3), e00449-20. https://doi.org/10.1128/mBio.00449-20

[10].  Galimberti, R., Torre, A C., Baztán, M C., & Rodriguez-Chiappetta, F., 2012, Emerging Systemic Fungal Infections. Clinics in Dermatology, 30(6), 633-650. https://doi.org/10.1016/j.clindermatol.2012.01.011

[11].  Kamali Sarvestani, H., Seifi, A., Falahatinejad, M., & Mahmoudi, S., 2022, Black Aspergilli as Causes of Otomycosis in the Era of Molecular Diagnostics, a Mini-Review. Journal De Mycologie Medicale, 32(2), 101240. https://doi.org/10.1016/j.mycmed.2021.101240

[12].  Aneja, K.R., Sharma, C., Joshi, R., 2010, Fungal Infection of the Ear: A Common Problem in the North Eastern Part of Haryana. International Journal of Pediatric Otorhinolaryngology, 74:604–607. https://doi.org/10.1016/j.ijporl.2010.03.001

[13].  Buonafina-Paz, M. D., Santos, F. A., Leite-Andrade, M. C., Alves, A. I., Bezerra, J. D., Leal, M. C., Robert, E., Pape, P. L., Lima-Neto, R. G., & Neves, R. P., 2022, Otomycosis Caused by the Cryptic and Emerging Species Aspergillus Sydowii: Two Case Reports. Future Microbiology,17:1437–1443. https://doi.org/10.2217/fmb-2022-0137

[14].  Bojanović, M., Stalević, M., Arsić-Arsenijević, V., Ignjatović, A., Ranđelović, M., Golubović, M., Živković-Marinkov, E., Koraćević, G., Stamenković, B., Otašević, S., 2023, Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review. Journal of Fungi, 9(6):662. http://doi.org/10.3390/jof9060662

[15].  Bluestone, C D., & Klein, J O., 1999, Consultation with the Specialist: Chronic Suppurative Otitis Media. Pediatrics in Review, 20(8), 277-279. https://doi.org/10.1542/pir.20-8-277

[16].  Patricia, M. T., 2014, Bailey & Scott’s Diagnostic Microbiology. (Elsevier, St. Louis, MO). 10.1309/LM5JC0PH0OGGBSZZ

[17].  Odds, F. C., & Bernaerts, R., 1994, CHROMagar Candida, A New Differential Isolation Medium for Presumptive Identification of Clinically Important Candida Species. Journal of Clinical Microbiology, 32(8):1923–1929. https://doi.org/10.1128/jcm.32.8.1923-1929.1994

[18].  Yegane Mogadam, A., Asadi, M. A., Dehghani, R., Hooshyar, H., 2009, The Prevalence of Otomycosis in Kasham Iran During 2001-2003. Jundishapur J Microbiol, 2(1):18–21.

[19].  Asoegwu, C. N., Oladele, R. O., Kanu, O. O., Peters, R. F., & Nwawolo, C. C., 2023. Clinical and Microbiological Profile of Otomycosis in Lagos, Nigeria. The Nigerian Postgraduate Medical Journal,30(2), 132–136. https://doi.org/10.4103/npmj.npmj_9_23

[20].  Prasad, S. C., Kotigadde, S., Shekhar, M., Thada, N. D., Prabhu, P., D' Souza, T., & Prasad, K. C., 2014, Primary Otomycosis in the Indian Subcontinent: Predisposing Factors, Microbiology, and classification. International Journal of Microbiology, 2014, 636493. https://doi.org/10.1155/2014/636493

[21].  Hagiwara, S., Tamura, T., Satoh, K., Kamewada, H., Nakano, M., Shinden, S., Yamaguchi, H., & Makimura, K., 2019, The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan. Mycopathologia, 184(1), 13–21. https://doi.org/10.1007/s11046-018-0299-9

[22].  Onotai, L., & Osuji, A. E., 2017, Otomycosis: Management Challenges and Outcomes in a Resource Poor Country. The Nigerian Health Journal, 16(4), 219. https://doi.org/10.60787/tnhj.v16i4.260

[23].  Aggarwal, S. K., Jaiswal, K., 2019, Fungal Profile and its Characteristics in Patients of Otomycosis‑A Prospective Study. National Journal of Laboratory Medicine, 8(4):MO04-MO07.

[24].  Gupta, S., Mahajan, B., 2015, Prevalence and Demographical Profile of Patients Presenting with Otomycosis. JK Science, 17:138‑42.

[25].  Ameye, S. A., Adeyemo, A., Eziyi, J. A., Amusa, Y. B., 2018, Clinical Profile of Otomycosis in a Sub‑Saharan African Tertiary Health Center. An International Journal of Otorhinolaryngology Clinics, 10:52‑5. http://doi.org/10.5005/jp-journals-10003-1290

[26].  Howlader, A., Nagarajan, P., Ragunathan, L., 2022, Mycological Profile in Otomycosis Patients and their Drug Sensitivity: A Cross-sectional Study at Union Territory of Puducherry, India, Journal of Clinical And Diagnostic Research, 16(10), DC11-DC15. https://www.doi.org/10.7860/JCDR/2022/57715/17073

[27].  Ashopa,V., Verma,U., Nareda, P., Gupta, E., prakash, P., 2020, Assessment of Risk Factors and Microbial Profile of Otomycosis in Patients Attending Tertiary Level Hospital of Western Rajasthan, India, Journal of clinical and diagnostic research.14(2),DC01-DC04. https://www.doi.org/10.7860/JCDR/2020/43153/13477

[28].  Taneja, M. K., 1998, Acute Otitis Media. Indian Journal of Otology, 4(4):161-164.

[29].  Mawson, S. R., and Ludman, H., 1979, In:Diseases of the Ear: A Textbook of Otology. (Chicago Yearbook Medical Publishing, pp 328-30).

[30].   Kunelskaya, V. Y. A., 1969, Significance of Fungal Flora in Chronic Suppurative Otitis Media. Vestn Otorinolaringol (Rus), 31(2):28–32.

[31].  Viswanatha, B., & Naseeruddin, K., 2011, Fungal Infections of the Ear in Immunocompromised Host: A Review. Mediterranean Journal of Hematology and Infectious Diseases, 3(1): e2011003. http://doi.org/10.4084/MJHID.2011.003

[32].  Anwar, K., & Gohar, M. S., 2014, Otomycosis; Clinical Features, Predisposing Factors and Treatment Implications. Pakistan Journal of Medical Sciences, 30(3):564–567. https://doi.org/10.12669/pjms.303.4106

[33].  Pontes, Z. B., Silva, A. D., Lima, E.deO., Guerra, M.deH., Oliveira, N. M., Carvalho, M.deF., & Guerra, F. S., 2009, Otomycosis: A Retrospective Study. Brazilian Journal of Otorhinolaryngology,75(3), 367–370. https://doi.org/10.1016/S1808-8694(15)30653-4

[34].  Padma, R., Mrunal, P., Ketki, P., Nidhi, A., 2023, Otitis Media and its Associated Risk Factors: An Investigation into Patients’ Knowledge, Attitudes, Practices, and Information Sources at a Hospital Setting. MGM Journal of Medical Sciences, 10(3): p 540-547.https://doi.org/10.4103/mgmj.mgmj_127_23

[35].  Suresh, S., Suresh, S., & Sivasamy, S., 2021, Prevalence of Otomycosis in Patients with Cerumen Impaction due to Earphone Usage During COVID-19. Indonesian Journal of Medical Sciences and Public Health. 2(1), 28 – 39. https://doi.org/10.11594/ijmp.02.01.04